Covid-19 News update: DCGI approves Johnson &Johnson single-dose vaccine for adolescents aged 12-17 years
Covid-19 News update: DCGI approves Johnson & Johnson single-dose vaccine for adolescents aged 12-17 years The Drug Controller General of India (DCGI) has approved the Johnson & Johnson single-dose vaccine for children aged 12 to 17 in India. The single-shot Covid vaccine developed by American pharmaceutical giant Johnson & Johnson showed 85 percent effectiveness in … Read more